Login / Signup

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database.

Yi ZhengXiaojing GuoChenxin ChenLijie ChiZhijian GuoJizhou LiangLianhui WeiXiao ChenXiaofei YeJia He
Published in: British journal of clinical pharmacology (2022)
This pharmacovigilance study systematically explored the four main toxicities of secukinumab and provided new safety signals based on past safety information. Some high-risk signals need to be given attention.
Keyphrases
  • adverse drug
  • ankylosing spondylitis
  • drug administration
  • healthcare
  • health information
  • social media
  • human health